HTLV-1 INFECTION
Clinical trials for HTLV-1 INFECTION explained in plain language.
Never miss a new study
Get alerted when new HTLV-1 INFECTION trials appear
Sign up with your email to follow new studies for HTLV-1 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare leukemia? drug combo trial launched
Disease control TerminatedThis early-stage trial tests adding lenalidomide to standard chemotherapy (EPOCH) for adult T-cell leukemia-lymphoma, a rare and aggressive blood cancer linked to HTLV-1 infection. The main goal is to find the safest dose of lenalidomide in this combination and check for side eff…
Matched conditions: HTLV-1 INFECTION
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 11:01 UTC
-
Researchers track survival in rare HTLV-1 blood cancer and chronic infection
Knowledge-focused OngoingThis study follows 69 adults infected with HTLV-1, some with a related blood cancer (ATL) and some without, to see how long they survive and how the virus behaves in their bodies. Researchers will collect blood samples and medical data over several years. No new treatments are be…
Matched conditions: HTLV-1 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC